Trial Profile
A Proof-of-Principle Study Investigating the Effect of Single Doses of NI-0801 on Nickel Induced Contact Dermatitis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Jun 2022
Price :
$35
*
At a glance
- Drugs NI 0801 (Primary)
- Indications Allergic contact dermatitis
- Focus Proof of concept; Therapeutic Use
- Sponsors Light Chain Bioscience; NovImmune SA
- 27 Oct 2014 New trial record